Cargando…
Is Newborn Screening the Ultimate Strategy to Reduce Diagnostic Delays in Pompe Disease? The Parent and Patient Perspective
Pompe disease (PD) is a rare, autosomal-recessively inherited deficiency in the enzyme acid α-glucosidase. It is a spectrum disorder; age at symptom onset and rate of deterioration can vary considerably. In affected infants prognosis is poor, such that without treatment most infants die within the f...
Autores principales: | Saich, Raymond, Brown, Renee, Collicoat, Maddy, Jenner, Catherine, Primmer, Jenna, Clancy, Beverley, Holland, Tarryn, Krinks, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422966/ https://www.ncbi.nlm.nih.gov/pubmed/33073001 http://dx.doi.org/10.3390/ijns6010001 |
Ejemplares similares
-
Newborn Screening for Pompe Disease
por: Sawada, Takaaki, et al.
Publicado: (2020) -
A Newborn Screening, Presymptomatically Identified Infant With Late-Onset Pompe Disease: Case Report, Parental Experience, and Recommendations
por: Wang, Raymond Y.
Publicado: (2020) -
Development of Newborn Screening for Pompe Disease
por: Hwu, Wuh-Liang, et al.
Publicado: (2020) -
Newborn Screening for Pompe Disease: Pennsylvania Experience
por: Ficicioglu, Can, et al.
Publicado: (2020) -
Muscle ultrasound in patients with late-onset Pompe disease identified by newborn screening
por: Jackson, David G., et al.
Publicado: (2023)